The Antimicrobial Peptide CRAMP-34 Eradicates Escherichia coli Biofilms by Interfering with the kduD-Dependent Network
Open Access
- 14 January 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (1) , 83
Abstract
Background/Objectives: Bacterial biofilms formed by Escherichia coli pose a significant challenge in veterinary medicine due to their intrinsic resistance to antibiotics. Antimicrobial peptides (AMPs) represent a promising alternative. AMPs exert their bactericidal activity by binding to negatively charged phospholipids in bacterial membranes via electrostatic interactions, leading to membrane disruption and rapid cell lysis. Methods: In vitro assays including MIC determination, biofilm eradication testing (crystal violet, colony counts, and CLSM), swimming motility, and EPS quantification were performed. CRISPR/Cas9 was used to construct and complement a kduD mutant. A transposon mutagenesis library was screened for biofilm-defective mutants. In an in vivo murine excisional wound infection model treated with the mouse cathelicidin-related antimicrobial peptide (CRAMP-34), wound closure and bacterial burden were monitored. Gene expression changes were analyzed via RT-qPCR. Results: CRAMP-34 effectively eradicated pre-formed biofilms of a clinically relevant, porcine-origin E. coli strain and promoted wound healing in the murine infection model. We conducted a genome-wide transposon mutagenesis screen, which identified kduD as a critical gene for robust biofilm formation. Functional characterization revealed that kduD deletion drastically impairs flagellar motility and alters exopolysaccharide production, leading to defective biofilm architecture without affecting growth. Notably, the anti-biofilm activity of CRAMP-34 phenocopied aspects of the kduD deletion, including motility inhibition and transcriptional repression of a common set of biofilm-related genes. Conclusions: This research highlights CRAMP-34 as a potent anti-biofilm agent and unveils kduD as a previously unrecognized regulator of E. coli biofilm development, which is also targeted by CRAMP-34.Keywords
All Related Versions
Funding Information
- National Center of Technology Innovation for Pigs (NCTIP-XDB19)
- Yunnan Province Science and Technology Department Key Research Development Plan (202403AC100013)
- Natural Science Foundation of Chongqing Municipality (CSTB2024NSCQ-MSX0373)
- Science and Technology Research Program Project of the Chongqing Municipal Education Commission (KJQN20240021)
This publication has 35 references indexed in Scilit:
- Biofilm formation by Gallibacterium anatis depends on TolC-mediated initial attachment of cellsThe Veterinary Journal, 2025
- Micro/nanomotors for biofilm remediation: Nanoarchitectonic breakthroughs with a focus on regulatory and clinical translation challengesBiomaterials, 2025
- Drug resistance detection of canine origin Escherichia coli in China and inhibition by genipinThe Veterinary Journal, 2025
- ArgR regulates motility and virulence through positive control of flagellar genes and inhibition of diguanylate cyclase expression in Aeromonas veroniiCommunications Biology, 2024
- Deciphering the code of temperature rise on aerobic granular sludge stability: A DSF-c-di-GMP mediated regulatory mechanismEnvironmental Research, 2024
- Evaluation of bottled drinking water and occurrence of multidrug-resistance and biofilm producing bacteria in NepalEnvironmental Pollution, 2023
- The biofilm life cycle: expanding the conceptual model of biofilm formationNature Reviews Microbiology, 2022
- The specific effect of (R)-(+)-pulegone on growth and biofilm formation in multi-drug resistant Escherichia coli and molecular mechanisms underlying the expression of pgaABCD genesBiomedicine & Pharmacotherapy, 2021
- Metabolic Fate of Unsaturated Glucuronic/Iduronic Acids from GlycosaminoglycansJournal of Biological Chemistry, 2015
- Escherichia coli kduD encodes an oxidoreductase that converts both sugar and steroid substratesApplied Microbiology and Biotechnology, 2014